LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
Clinical trial NCT02964247 · COMPLETED
Trial details
- NCT number
- NCT02964247
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-03
- Primary completion
- 2018-05-04
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.